Chronic heart failure with preserved ejection fraction
Conditions
Interventions
Treatment group:Conventional western medicine treatment + Yangxinxue granules
Control group:Conventional western medicine treatment
Sponsors
Qionglai Hospital of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
40 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1.It meets the diagnostic criteria of Western medicine HFpEF, and the symptoms are greater than 3 months. 2.In line with the traditional Chinese medicine heart-blood deficiency and heart-yang depression syndrome diagnosis standards. 3.Patients who were in a clinically stable state (treated with fixed dose Western medicine for more than 2 weeks) before enrollment, or who were diagnosed with chronic heart failure for the first time and did not start treatment. 4.The Classification of cardiac function is between grade ? and ?. 5.Cooperate with regular visits and follow up. 6.The patient gives informed consent and signs the informed consent.
Exclusion criteria
Exclusion criteria: 1. Under 40 years old or over 80 years old. 2. Patients with obstructive heart disease, constrictive pericarditis, pericardial tamponade, valvular heart disease, pulmonary embolism, and acute myocardial infarction within 2 months; Patients with severe and uncontrolled arrhythmias; Patients with heart failure combined with uncontrolled infection; And patients with other medical conditions that affect the determination of efficacy. 3. Patients with severe primary diseases of other medical systems, such as liver, kidney, blood system and endocrine system. 4. Patients with mental disorders who cannot normally cooperate with the completion of the study. 5. Pregnant and lactating women. 6. Patients who are allergic to the drugs in this study protocol or to specific components thereof. 7. Patients who cannot take medicine according to regulations, which affects the evaluation of efficacy, and whose clinical data are incomplete and cannot accurately judge the effect of drug treatment. 8. Can not cooperate with the improvement of relevant inspectors.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Effectiveness of treatment; | — |
Secondary
| Measure | Time frame |
|---|---|
| Effects on RAAS and inflammatory indicators; | — |
Countries
China
Contacts
Public ContactZhou Qian
Qionglai Hospital of Traditional Chinese Medicine
Outcome results
None listed